Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation

Background Laparoscopic left lateral sectionectomy (LLS) has gained popularity in its use for benign and malignant tumors. This report describes the evolution of the authors’ experience using laparoscopic LLS for different indications including living liver donation. Methods Between January 2004 and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgical endoscopy 2011-01, Vol.25 (1), p.79-87
Hauptverfasser: Troisi, Roberto Ivan, Van Huysse, Jacques, Berrevoet, Frederik, Vandenbossche, Bert, Sainz-Barriga, Mauricio, Vinci, Alessio, Ricciardi, Salvatore, Bocchetti, Tommaso, Rogiers, Xavier, de Hemptinne, Bernard
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 87
container_issue 1
container_start_page 79
container_title Surgical endoscopy
container_volume 25
creator Troisi, Roberto Ivan
Van Huysse, Jacques
Berrevoet, Frederik
Vandenbossche, Bert
Sainz-Barriga, Mauricio
Vinci, Alessio
Ricciardi, Salvatore
Bocchetti, Tommaso
Rogiers, Xavier
de Hemptinne, Bernard
description Background Laparoscopic left lateral sectionectomy (LLS) has gained popularity in its use for benign and malignant tumors. This report describes the evolution of the authors’ experience using laparoscopic LLS for different indications including living liver donation. Methods Between January 2004 and January 2009, 37 consecutive patients underwent laparoscopic LLS for benign, primary, and metastatic liver diseases, and for one case of living liver donation. Resection of malignant tumors was indicated for 19 (51%) of the 37 patients. Results All but three patients (deceased due to metastatic cancer disease) are alive and well after a median follow-up period of 20 months (range, 8–46 months). Liver cell adenomas (72%) were the main indication among benign tumors, and colorectal liver metastases (84%) were the first indication of malignancy. One case of live liver donation was performed. Whereas 16 patients (43%) had undergone a previous abdominal surgery, 3 patients (8%) had LLS combined with bowel resection. The median operation time was of 195 min (range, 115–300 min), and the median blood loss was of 50 ml (range, 0–500 ml). Mild to severe steatosis was noted in 7 patients (19%) and aspecific portal inflammation in 11 patients (30%). A median free margin of 5 mm (range, 5–27 mm) was achieved for all cancer patients. The overall recurrence rate for colorectal liver metastases was of 44% (7 patients), but none recurred at the surgical margin. No conversion to laparotomy was recorded, and the overall morbidity rate was 8.1% (1 grade 1 and 2 grade 2 complications). The median hospital stay was 6 days (range, 2–10 days). Conclusions Laparoscopic LLS without portal clamping can be performed safely for cases of benign and malignant liver disease with minimal blood loss and overall morbidity, free resection margins, and a favorable outcome. As the ultimate step of the learning curve, laparoscopic LLS could be routinely proposed, potentially increasing the donor pool for living-related liver transplantation.
doi_str_mv 10.1007/s00464-010-1133-8
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3003798</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2218158731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-568513f57c16db1890f3ee3363eaa818f7033cd7fbc91d917e1e8097d843b1623</originalsourceid><addsrcrecordid>eNp1kc-OFCEQxonRuOPqA3gxxMRjKwX9BzyYmM26a7KJHvRMaLp6hk03jECP2XfxYaUz464evFBQ_Oqrgo-Ql8DeAmPdu8RY3dYVA1YBCFHJR2QDteAV5yAfkw1TglW8U_UZeZbSLSu4guYpOeOsEbxp1Yb8ujyEackueBpGOpm9iSHZsHeWTjjmkskYzUQT2hUqa5jv6E-Xd2HJNO-Qfo3Obyeks_G4HDC-L9kYlu2ORjxVrdI9erf11PihkFPZGl_qlznERHOgkzsUmTVgpEPwZq17Tp6MZkr44hTPyfdPl98urqubL1efLz7eVLZWMldNKxsQY9NZaIcepGKjQBSiFWiMBDl2TAg7dGNvFQwKOgSUTHWDrEUPLRfn5MNRd7_0Mw4WfS5v1vvoZhPvdDBO_3vj3U5vw0ELxkSnZBF4fRKI4ceCKevbsERfZtalfyc5cFYgOEK2fHGKON43AKZXP_XRT83Wc_FTr8Kv_p7svuKPgQV4cwJMsmYao_HWpQdOSICCFY4fubRf_cL4MOH_u_8GkgW83A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>818782120</pqid></control><display><type>article</type><title>Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Troisi, Roberto Ivan ; Van Huysse, Jacques ; Berrevoet, Frederik ; Vandenbossche, Bert ; Sainz-Barriga, Mauricio ; Vinci, Alessio ; Ricciardi, Salvatore ; Bocchetti, Tommaso ; Rogiers, Xavier ; de Hemptinne, Bernard</creator><creatorcontrib>Troisi, Roberto Ivan ; Van Huysse, Jacques ; Berrevoet, Frederik ; Vandenbossche, Bert ; Sainz-Barriga, Mauricio ; Vinci, Alessio ; Ricciardi, Salvatore ; Bocchetti, Tommaso ; Rogiers, Xavier ; de Hemptinne, Bernard</creatorcontrib><description>Background Laparoscopic left lateral sectionectomy (LLS) has gained popularity in its use for benign and malignant tumors. This report describes the evolution of the authors’ experience using laparoscopic LLS for different indications including living liver donation. Methods Between January 2004 and January 2009, 37 consecutive patients underwent laparoscopic LLS for benign, primary, and metastatic liver diseases, and for one case of living liver donation. Resection of malignant tumors was indicated for 19 (51%) of the 37 patients. Results All but three patients (deceased due to metastatic cancer disease) are alive and well after a median follow-up period of 20 months (range, 8–46 months). Liver cell adenomas (72%) were the main indication among benign tumors, and colorectal liver metastases (84%) were the first indication of malignancy. One case of live liver donation was performed. Whereas 16 patients (43%) had undergone a previous abdominal surgery, 3 patients (8%) had LLS combined with bowel resection. The median operation time was of 195 min (range, 115–300 min), and the median blood loss was of 50 ml (range, 0–500 ml). Mild to severe steatosis was noted in 7 patients (19%) and aspecific portal inflammation in 11 patients (30%). A median free margin of 5 mm (range, 5–27 mm) was achieved for all cancer patients. The overall recurrence rate for colorectal liver metastases was of 44% (7 patients), but none recurred at the surgical margin. No conversion to laparotomy was recorded, and the overall morbidity rate was 8.1% (1 grade 1 and 2 grade 2 complications). The median hospital stay was 6 days (range, 2–10 days). Conclusions Laparoscopic LLS without portal clamping can be performed safely for cases of benign and malignant liver disease with minimal blood loss and overall morbidity, free resection margins, and a favorable outcome. As the ultimate step of the learning curve, laparoscopic LLS could be routinely proposed, potentially increasing the donor pool for living-related liver transplantation.</description><identifier>ISSN: 0930-2794</identifier><identifier>EISSN: 1432-2218</identifier><identifier>DOI: 10.1007/s00464-010-1133-8</identifier><identifier>PMID: 20532569</identifier><identifier>CODEN: SUREEX</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject><![CDATA[Abdomen ; Abdominal Surgery ; Adenocarcinoma - secondary ; Adenocarcinoma - surgery ; Adenoma - surgery ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols - administration & dosage ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Biological and medical sciences ; Blood Loss, Surgical ; Camptothecin - administration & dosage ; Camptothecin - analogs & derivatives ; Carcinoma, Hepatocellular - drug therapy ; Carcinoma, Hepatocellular - surgery ; Combined Modality Therapy ; Digestive system. Abdomen ; Disease ; Disease-Free Survival ; Endoscopy ; Female ; Fluorouracil - administration & dosage ; Follow-Up Studies ; Gastroenterology ; Gastrointestinal Stromal Tumors - secondary ; Gastrointestinal Stromal Tumors - surgery ; Gynecology ; Hepatectomy - methods ; Hepatology ; Hospitals ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Laparoscopy ; Laparoscopy - methods ; Length of Stay - statistics & numerical data ; Leucovorin - administration & dosage ; Liver ; Liver Neoplasms - drug therapy ; Liver Neoplasms - secondary ; Liver Neoplasms - surgery ; Liver Transplantation ; Liver, biliary tract, pancreas, portal circulation, spleen ; Living Donors ; Male ; Medical sciences ; Medicine ; Medicine & Public Health ; Melanoma - secondary ; Melanoma - surgery ; Metastasis ; Middle Aged ; Morbidity ; Mortality ; Organoplatinum Compounds - administration & dosage ; Patients ; Postoperative Complications - epidemiology ; Proctology ; Retrospective Studies ; Surgeons ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the digestive system ; Surgical techniques ; Tissue and Organ Harvesting - methods ; Tomography ; Transplants & implants ; Tumors]]></subject><ispartof>Surgical endoscopy, 2011-01, Vol.25 (1), p.79-87</ispartof><rights>The Author(s) 2010</rights><rights>2015 INIST-CNRS</rights><rights>Springer Science+Business Media, LLC 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-568513f57c16db1890f3ee3363eaa818f7033cd7fbc91d917e1e8097d843b1623</citedby><cites>FETCH-LOGICAL-c498t-568513f57c16db1890f3ee3363eaa818f7033cd7fbc91d917e1e8097d843b1623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00464-010-1133-8$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00464-010-1133-8$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23811693$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20532569$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Troisi, Roberto Ivan</creatorcontrib><creatorcontrib>Van Huysse, Jacques</creatorcontrib><creatorcontrib>Berrevoet, Frederik</creatorcontrib><creatorcontrib>Vandenbossche, Bert</creatorcontrib><creatorcontrib>Sainz-Barriga, Mauricio</creatorcontrib><creatorcontrib>Vinci, Alessio</creatorcontrib><creatorcontrib>Ricciardi, Salvatore</creatorcontrib><creatorcontrib>Bocchetti, Tommaso</creatorcontrib><creatorcontrib>Rogiers, Xavier</creatorcontrib><creatorcontrib>de Hemptinne, Bernard</creatorcontrib><title>Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation</title><title>Surgical endoscopy</title><addtitle>Surg Endosc</addtitle><addtitle>Surg Endosc</addtitle><description>Background Laparoscopic left lateral sectionectomy (LLS) has gained popularity in its use for benign and malignant tumors. This report describes the evolution of the authors’ experience using laparoscopic LLS for different indications including living liver donation. Methods Between January 2004 and January 2009, 37 consecutive patients underwent laparoscopic LLS for benign, primary, and metastatic liver diseases, and for one case of living liver donation. Resection of malignant tumors was indicated for 19 (51%) of the 37 patients. Results All but three patients (deceased due to metastatic cancer disease) are alive and well after a median follow-up period of 20 months (range, 8–46 months). Liver cell adenomas (72%) were the main indication among benign tumors, and colorectal liver metastases (84%) were the first indication of malignancy. One case of live liver donation was performed. Whereas 16 patients (43%) had undergone a previous abdominal surgery, 3 patients (8%) had LLS combined with bowel resection. The median operation time was of 195 min (range, 115–300 min), and the median blood loss was of 50 ml (range, 0–500 ml). Mild to severe steatosis was noted in 7 patients (19%) and aspecific portal inflammation in 11 patients (30%). A median free margin of 5 mm (range, 5–27 mm) was achieved for all cancer patients. The overall recurrence rate for colorectal liver metastases was of 44% (7 patients), but none recurred at the surgical margin. No conversion to laparotomy was recorded, and the overall morbidity rate was 8.1% (1 grade 1 and 2 grade 2 complications). The median hospital stay was 6 days (range, 2–10 days). Conclusions Laparoscopic LLS without portal clamping can be performed safely for cases of benign and malignant liver disease with minimal blood loss and overall morbidity, free resection margins, and a favorable outcome. As the ultimate step of the learning curve, laparoscopic LLS could be routinely proposed, potentially increasing the donor pool for living-related liver transplantation.</description><subject>Abdomen</subject><subject>Abdominal Surgery</subject><subject>Adenocarcinoma - secondary</subject><subject>Adenocarcinoma - surgery</subject><subject>Adenoma - surgery</subject><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blood Loss, Surgical</subject><subject>Camptothecin - administration &amp; dosage</subject><subject>Camptothecin - analogs &amp; derivatives</subject><subject>Carcinoma, Hepatocellular - drug therapy</subject><subject>Carcinoma, Hepatocellular - surgery</subject><subject>Combined Modality Therapy</subject><subject>Digestive system. Abdomen</subject><subject>Disease</subject><subject>Disease-Free Survival</subject><subject>Endoscopy</subject><subject>Female</subject><subject>Fluorouracil - administration &amp; dosage</subject><subject>Follow-Up Studies</subject><subject>Gastroenterology</subject><subject>Gastrointestinal Stromal Tumors - secondary</subject><subject>Gastrointestinal Stromal Tumors - surgery</subject><subject>Gynecology</subject><subject>Hepatectomy - methods</subject><subject>Hepatology</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Laparoscopy</subject><subject>Laparoscopy - methods</subject><subject>Length of Stay - statistics &amp; numerical data</subject><subject>Leucovorin - administration &amp; dosage</subject><subject>Liver</subject><subject>Liver Neoplasms - drug therapy</subject><subject>Liver Neoplasms - secondary</subject><subject>Liver Neoplasms - surgery</subject><subject>Liver Transplantation</subject><subject>Liver, biliary tract, pancreas, portal circulation, spleen</subject><subject>Living Donors</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Melanoma - secondary</subject><subject>Melanoma - surgery</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Organoplatinum Compounds - administration &amp; dosage</subject><subject>Patients</subject><subject>Postoperative Complications - epidemiology</subject><subject>Proctology</subject><subject>Retrospective Studies</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the digestive system</subject><subject>Surgical techniques</subject><subject>Tissue and Organ Harvesting - methods</subject><subject>Tomography</subject><subject>Transplants &amp; implants</subject><subject>Tumors</subject><issn>0930-2794</issn><issn>1432-2218</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kc-OFCEQxonRuOPqA3gxxMRjKwX9BzyYmM26a7KJHvRMaLp6hk03jECP2XfxYaUz464evFBQ_Oqrgo-Ql8DeAmPdu8RY3dYVA1YBCFHJR2QDteAV5yAfkw1TglW8U_UZeZbSLSu4guYpOeOsEbxp1Yb8ujyEackueBpGOpm9iSHZsHeWTjjmkskYzUQT2hUqa5jv6E-Xd2HJNO-Qfo3Obyeks_G4HDC-L9kYlu2ORjxVrdI9erf11PihkFPZGl_qlznERHOgkzsUmTVgpEPwZq17Tp6MZkr44hTPyfdPl98urqubL1efLz7eVLZWMldNKxsQY9NZaIcepGKjQBSiFWiMBDl2TAg7dGNvFQwKOgSUTHWDrEUPLRfn5MNRd7_0Mw4WfS5v1vvoZhPvdDBO_3vj3U5vw0ELxkSnZBF4fRKI4ceCKevbsERfZtalfyc5cFYgOEK2fHGKON43AKZXP_XRT83Wc_FTr8Kv_p7svuKPgQV4cwJMsmYao_HWpQdOSICCFY4fubRf_cL4MOH_u_8GkgW83A</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Troisi, Roberto Ivan</creator><creator>Van Huysse, Jacques</creator><creator>Berrevoet, Frederik</creator><creator>Vandenbossche, Bert</creator><creator>Sainz-Barriga, Mauricio</creator><creator>Vinci, Alessio</creator><creator>Ricciardi, Salvatore</creator><creator>Bocchetti, Tommaso</creator><creator>Rogiers, Xavier</creator><creator>de Hemptinne, Bernard</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20110101</creationdate><title>Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation</title><author>Troisi, Roberto Ivan ; Van Huysse, Jacques ; Berrevoet, Frederik ; Vandenbossche, Bert ; Sainz-Barriga, Mauricio ; Vinci, Alessio ; Ricciardi, Salvatore ; Bocchetti, Tommaso ; Rogiers, Xavier ; de Hemptinne, Bernard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-568513f57c16db1890f3ee3363eaa818f7033cd7fbc91d917e1e8097d843b1623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Abdomen</topic><topic>Abdominal Surgery</topic><topic>Adenocarcinoma - secondary</topic><topic>Adenocarcinoma - surgery</topic><topic>Adenoma - surgery</topic><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blood Loss, Surgical</topic><topic>Camptothecin - administration &amp; dosage</topic><topic>Camptothecin - analogs &amp; derivatives</topic><topic>Carcinoma, Hepatocellular - drug therapy</topic><topic>Carcinoma, Hepatocellular - surgery</topic><topic>Combined Modality Therapy</topic><topic>Digestive system. Abdomen</topic><topic>Disease</topic><topic>Disease-Free Survival</topic><topic>Endoscopy</topic><topic>Female</topic><topic>Fluorouracil - administration &amp; dosage</topic><topic>Follow-Up Studies</topic><topic>Gastroenterology</topic><topic>Gastrointestinal Stromal Tumors - secondary</topic><topic>Gastrointestinal Stromal Tumors - surgery</topic><topic>Gynecology</topic><topic>Hepatectomy - methods</topic><topic>Hepatology</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Laparoscopy</topic><topic>Laparoscopy - methods</topic><topic>Length of Stay - statistics &amp; numerical data</topic><topic>Leucovorin - administration &amp; dosage</topic><topic>Liver</topic><topic>Liver Neoplasms - drug therapy</topic><topic>Liver Neoplasms - secondary</topic><topic>Liver Neoplasms - surgery</topic><topic>Liver Transplantation</topic><topic>Liver, biliary tract, pancreas, portal circulation, spleen</topic><topic>Living Donors</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Melanoma - secondary</topic><topic>Melanoma - surgery</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Organoplatinum Compounds - administration &amp; dosage</topic><topic>Patients</topic><topic>Postoperative Complications - epidemiology</topic><topic>Proctology</topic><topic>Retrospective Studies</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the digestive system</topic><topic>Surgical techniques</topic><topic>Tissue and Organ Harvesting - methods</topic><topic>Tomography</topic><topic>Transplants &amp; implants</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Troisi, Roberto Ivan</creatorcontrib><creatorcontrib>Van Huysse, Jacques</creatorcontrib><creatorcontrib>Berrevoet, Frederik</creatorcontrib><creatorcontrib>Vandenbossche, Bert</creatorcontrib><creatorcontrib>Sainz-Barriga, Mauricio</creatorcontrib><creatorcontrib>Vinci, Alessio</creatorcontrib><creatorcontrib>Ricciardi, Salvatore</creatorcontrib><creatorcontrib>Bocchetti, Tommaso</creatorcontrib><creatorcontrib>Rogiers, Xavier</creatorcontrib><creatorcontrib>de Hemptinne, Bernard</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Surgical endoscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Troisi, Roberto Ivan</au><au>Van Huysse, Jacques</au><au>Berrevoet, Frederik</au><au>Vandenbossche, Bert</au><au>Sainz-Barriga, Mauricio</au><au>Vinci, Alessio</au><au>Ricciardi, Salvatore</au><au>Bocchetti, Tommaso</au><au>Rogiers, Xavier</au><au>de Hemptinne, Bernard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation</atitle><jtitle>Surgical endoscopy</jtitle><stitle>Surg Endosc</stitle><addtitle>Surg Endosc</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>25</volume><issue>1</issue><spage>79</spage><epage>87</epage><pages>79-87</pages><issn>0930-2794</issn><eissn>1432-2218</eissn><coden>SUREEX</coden><abstract>Background Laparoscopic left lateral sectionectomy (LLS) has gained popularity in its use for benign and malignant tumors. This report describes the evolution of the authors’ experience using laparoscopic LLS for different indications including living liver donation. Methods Between January 2004 and January 2009, 37 consecutive patients underwent laparoscopic LLS for benign, primary, and metastatic liver diseases, and for one case of living liver donation. Resection of malignant tumors was indicated for 19 (51%) of the 37 patients. Results All but three patients (deceased due to metastatic cancer disease) are alive and well after a median follow-up period of 20 months (range, 8–46 months). Liver cell adenomas (72%) were the main indication among benign tumors, and colorectal liver metastases (84%) were the first indication of malignancy. One case of live liver donation was performed. Whereas 16 patients (43%) had undergone a previous abdominal surgery, 3 patients (8%) had LLS combined with bowel resection. The median operation time was of 195 min (range, 115–300 min), and the median blood loss was of 50 ml (range, 0–500 ml). Mild to severe steatosis was noted in 7 patients (19%) and aspecific portal inflammation in 11 patients (30%). A median free margin of 5 mm (range, 5–27 mm) was achieved for all cancer patients. The overall recurrence rate for colorectal liver metastases was of 44% (7 patients), but none recurred at the surgical margin. No conversion to laparotomy was recorded, and the overall morbidity rate was 8.1% (1 grade 1 and 2 grade 2 complications). The median hospital stay was 6 days (range, 2–10 days). Conclusions Laparoscopic LLS without portal clamping can be performed safely for cases of benign and malignant liver disease with minimal blood loss and overall morbidity, free resection margins, and a favorable outcome. As the ultimate step of the learning curve, laparoscopic LLS could be routinely proposed, potentially increasing the donor pool for living-related liver transplantation.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><pmid>20532569</pmid><doi>10.1007/s00464-010-1133-8</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0930-2794
ispartof Surgical endoscopy, 2011-01, Vol.25 (1), p.79-87
issn 0930-2794
1432-2218
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3003798
source MEDLINE; SpringerLink Journals
subjects Abdomen
Abdominal Surgery
Adenocarcinoma - secondary
Adenocarcinoma - surgery
Adenoma - surgery
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biological and medical sciences
Blood Loss, Surgical
Camptothecin - administration & dosage
Camptothecin - analogs & derivatives
Carcinoma, Hepatocellular - drug therapy
Carcinoma, Hepatocellular - surgery
Combined Modality Therapy
Digestive system. Abdomen
Disease
Disease-Free Survival
Endoscopy
Female
Fluorouracil - administration & dosage
Follow-Up Studies
Gastroenterology
Gastrointestinal Stromal Tumors - secondary
Gastrointestinal Stromal Tumors - surgery
Gynecology
Hepatectomy - methods
Hepatology
Hospitals
Humans
Investigative techniques, diagnostic techniques (general aspects)
Laparoscopy
Laparoscopy - methods
Length of Stay - statistics & numerical data
Leucovorin - administration & dosage
Liver
Liver Neoplasms - drug therapy
Liver Neoplasms - secondary
Liver Neoplasms - surgery
Liver Transplantation
Liver, biliary tract, pancreas, portal circulation, spleen
Living Donors
Male
Medical sciences
Medicine
Medicine & Public Health
Melanoma - secondary
Melanoma - surgery
Metastasis
Middle Aged
Morbidity
Mortality
Organoplatinum Compounds - administration & dosage
Patients
Postoperative Complications - epidemiology
Proctology
Retrospective Studies
Surgeons
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the digestive system
Surgical techniques
Tissue and Organ Harvesting - methods
Tomography
Transplants & implants
Tumors
title Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T08%3A42%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evolution%20of%20laparoscopic%20left%20lateral%20sectionectomy%20without%20the%20Pringle%20maneuver:%20through%20resection%20of%20benign%20and%20malignant%20tumors%20to%20living%20liver%20donation&rft.jtitle=Surgical%20endoscopy&rft.au=Troisi,%20Roberto%20Ivan&rft.date=2011-01-01&rft.volume=25&rft.issue=1&rft.spage=79&rft.epage=87&rft.pages=79-87&rft.issn=0930-2794&rft.eissn=1432-2218&rft.coden=SUREEX&rft_id=info:doi/10.1007/s00464-010-1133-8&rft_dat=%3Cproquest_pubme%3E2218158731%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=818782120&rft_id=info:pmid/20532569&rfr_iscdi=true